Sort
89,613 grants matching “depression”
Cardiovascular Toxicity of Environmental Aldehydes
$1,437,761Aruni Bhatnagar Bhatnagar · University Of Louisville · P01 · FY2006 · ES
A comprehensive dissection of cell types, circuits and molecular adaptations during opioid use
$1,437,329Gregory Scherrer · Univ Of North Carolina Chapel Hill · R01 · FY2021 · DA
A Pragmatic Trial of Parent-focused Prevention in Pediatric Primary Care
$1,437,320Margaret Kuklinski · University Of Washington · UH3 · FY2021 · AT
Motor Activity Research Consortium for Health (mMarch)
$1,436,888Kathleen R Merikangas · National Institute Of Mental Health · ZIA · FY2023 · MH
Molecular and Cellular Mechanisms of Experience-Dependent Cortical Processing
$1,436,762Kuan Wang · National Institute Of Mental Health · ZIA · FY2016 · MH
Molecular Mechanisms Of Synapse Development And Plasticity
$1,436,574Bai Lu · Child Health And Human Development · Z01 · FY2007 · HD
Advancing RNA Therapeutics for Huntingtonâs Disease
$1,436,316Neil Aronin · Univ Of Massachusetts Med Sch Worcester · U01 · FY2020 · NS
Studies of Central Nervous System Functional Anatomy
$1,435,998Miles A. Herkenham · National Institute Of Mental Health · ZIA · FY2016 · MH
ASSEMBLY AND TARGETING OF NEURAL RECEPTORS AND CHANNELS
$1,435,361University Of California San Francisco · P50 · FY2005 · MH
Cornell ACISR for Late Life Depression
$1,433,561Weill Medical College Of Cornell Univ · P30 · FY2004 · MH
Transdisciplinary Research, Equity and Engagement Center for Advancing Behavioral Health
$1,433,258Lisa Marie Cacari Stone · University Of New Mexico Health Scis Ctr · U54 · FY2017 · MD
Center for Research on Botanical Dietary Supplements
$1,431,593Diane Birt · Iowa State University · P50 · FY2009 · AT
Peripherally-restricted and long-acting kappa-opioid receptor (LA-KOR) agonists for pain
$1,431,363Pierre Riviere · Peptide Logic, Llc · R44 · FY2019 · DA
Interdepartmental Stroke Program
$1,431,257Michael A Moskowitz · Massachusetts General Hospital · P50 · FY2007 · NS
fMRI Studies of Risk for Mood and Anxiety Disorders in Children
$1,431,112Daniel Pine · National Institute Of Mental Health · ZIA · FY2019 · MH
Molecular and Cellular Mechanisms of Experience-Dependent Cortical Processing
$1,430,692Kuan Wang · National Institute Of Mental Health · ZIA · FY2010 · MH
Molecular Mechanisms of Synapse Development and Plasticity
$1,428,013Zheng Li · National Institute Of Mental Health · ZIA · FY2021 · MH
Characterizing Cognitive Decline in Late Life Depression: The ADNI-D Project
$1,427,244Robert Scott Mackin · University Of California, San Francisco · R01 · FY2024 · MH
Apathy in Alzheimer's Disease Methyphenidate Trial II (ADMET II)
$1,426,649Jacobo E. Mintzer · Medical University Of South Carolina · R01 · FY2015 · AG
Next generation drugs for bipolar depression and maintenance
$1,425,888Thomas H Large · Blue Oak Pharmaceuticals, Inc. · R44 · FY2021 · MH
Ryan® CompanionBot for Assisting Older Adults with Early-Stage Alzheimer's Disease and Dementia
$1,425,801Mohammad Mahoor · Dream Face Technologies, Llc · SB1 · FY2025 · AG
Physiology, Psychology, and Genetics of Obesity
$1,425,532Jack A. Yanovski · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2020 · HD
Ryan® CompanionBot for Assisting Older Adults with Early-Stage Alzheimer's Disease and Dementia
$1,424,731Mohammad Mahoor · Dream Face Technologies, Llc · SB1 · FY2024 · AG
Course and Outcome of Bipolar Disorder in Youth
$1,424,662Boris Birmaher · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · MH
Pragmatic Trial of the Effectiveness and Cost-Effectiveness of Dementia Care
$1,424,644David B. Reuben · University Of California Los Angeles · R01 · FY2023 · AG